Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR

Journal of Clinical Microbiology

Volumn 41, Issue 2, 2003, Pages 608-612

  Lukaszuk, Krzysztof ^a,b   Liss, Joanna ^a,b   Wozniak, Izabela ^a   Emerich, Janusz ^a   Wójcikowski, Czesław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Prophylactic Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS DNA;

ARTICLE; CANCER CELL; CANCER STAGING; CLUSTER ANALYSIS; DNA DETERMINATION; DNA INTEGRATION; DNA ISOLATION; EPISOME; FEMALE; GENE FREQUENCY; GENE OVEREXPRESSION; GENE REPRESSION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; NONHUMAN; OPEN READING FRAME; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SUPPRESSOR GENE; TECHNIQUE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS TYPING; WART VIRUS;

DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPOVAVIRIDAE;

EID: 0037316582     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.2.608-612.2003     Document Type: Article

References (28)

1. Bernard, B. A., C. Bailly, M.-C. Lenoir, M. Darmon, F. Thierry, and M. Yaniv. 1989. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 63:4317-4324.
2. Chen, C. M., M. P. Shyu, L. C. Au, H. W. Chu, W. T. Cheng, and K. B. Choo. 1994. Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction. J. Med. Virol. 44:206-211.
3. Cullen, A. P., R. Reid, M. Campion, and A. T. Lorincz. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:606-612.
4. Daniel, B., G. Mukherjee, L. Seshadri, E. Vallikad, and S. Krishna. 1995. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J. Gen. Virol. 76:2589-2593.
5. Daniel, B., A. Rangarajan, G. Mukherjee, E. Vallikad, and S. Krishna. 1997. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol. 78:1095-1101.
6. Durst, M., A. Kleinheinz, M. Hotz, and L. Gissman. 1985. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors. J. Gen. Virol. 66:1515-1522.
7. Fuchs, P., and H. Pfister. 1994. Transcription of papillomavirus genomes. Intervirology 37:159-167.
8. Jeon, S., L. Allen-Hoffmann, and P. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
9. Jeon, S., and P. F. Lambert. 1995. Integration of HPV-16 DNA into the human genome leads to increased stability of E6/E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
10. Kado, S., Y. Kawamata, Y. Shino, T. Kasai, K. Kubota, H. Iwasaki, I. Fukazawa, H. Takano, T. Nunoyama, A. Mitsuhashi, S. Seklya, and H. Shirasawa. 2001. Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynecol. Oncol. 81:47-52.
11. Kalantari, M., E. Blennow, B. Hagmar, and B. Johansson. 2001. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn. Mol. Pathol. 10:46-54.
12. Karlsen, F., M. Kalantari, A. Jenkins, E. Pettersen, G. Kristensen, R. Holm, B. Johansson, and B. Hagmar. 1996. Use of multiplex PCR primer sets for optimal detection of human papillomavirus. J. Clin. Microbiol. 34:2095-2100.
13. Kessis, T. D., D. C. Connolly, L. Hedrick, and K. R. Cho. 1996. Expression of HPV 16 E6 or E7 increases integration of foreign DNA. Oncogene 13:427-431.
14. Klaes, R., S. M. Woerner, R. Ridder, N. Wentzensen, M. Duerst, A. Schneider, B. Lotz, P. Melsheimer, and D. M. von Knebel. 1999. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59:6132-6136.
15. Liss, J. 2000. Ph.D. thesis. Medical University of Gdansk, Gdansk, Poland.
16. Liss, J., K. Łukaszuk, J. Gulczyñski, M. Zwaliñski, I. Woüniak, J. Emerich, and C. Wójcikowski. 2002. Wystêpowanie DNA wirusa HPV u pacjentek z rakiem szyjki macicy w regionie gdañskim. Gin. Pol. 73:740-745. (In Polish.)
17. Lukaszuk, J. K., Liss, J. Zalewski, M. Roter, B. Brzóska, and J. Dêhniak. 2001. The estimation of HPV infection in cytological scrapes in asymptotic patients. Wiad. Lek. 54:508-515.
18. Mauricio, L., T. R. Lima, D. Foguel, and J. Silva. 2000. DNA tightens the dimeric DNA-binding domain of human papillomavirus E2 protein without changes in volume. Proc. Natl. Acad. Sci. USA 97:14289-14294.
19. Mayrand, M., F. Coutlee, C. Hankins, N. Lapointe, P. Forest, M. Ladurantaye, and M. Roger. 2000. Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analisys. J. Clin. Microbiol. 38:3388-3393.
20. Pirami, L., V. Giache, and A. Becciolini. 1997. Analysis of HPV 16, 18, 31 and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J. Clin. Pathol. 50:600-6004.
21. Romanczuk, H., F. Thierry and P. M. Howley. 1990. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64:2849-2859.
22. Stunkel, W., Z. Huang, S. Tan, M. O'Connor, and H. Bernard. 2000. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J. Virol. 74:2489-2501.
23. Thierry, F., and P. M. Howley. 1991. Functional analysis of E2 mediated repression of the HPV 18 P105 promotor. New Biol. 3:90-100.
24. Titolo, S., A. Pelleetier, F. Sauve, K. Brault, E. Wardrop, and P. W. White. 1999. Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin. J. Virol. 72:2567-2576.
25. Van den Brule, A. J., J. M. Walboomers, M. Du Maine, P. Kenemans, and C. J. Meijer. 1991. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int. J. Cancer 48:404-408.
26. Van Horn, G., S. Sheikh, and S. Khan. 2001. Regulation of human papillomavirus type 1 replication by the viral E2 protein. Virology 287:214-224.
27. Vernon, S., E. Unger, D. Miller, D. Lee, and W. Reeves. 1997. Association of human papillomavirus type 16 integration in the E2 gene with poor diseasefree survival from cervical cancer. Int. J. Cancer 74:50-56.
28. Yshinouchi, M., A. Hongo, K. Nakamura, J. Kodama, S. Itoh, H. Sakai, and T. Kudo. 1999. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J. Clin. Microbiol. 37:3514-3517.